Research programme: topical therapeutics for pain and nasal congestion - China Pharmaceutical University/ Johnson and Johnson Innovation

Drug Profile

Research programme: topical therapeutics for pain and nasal congestion - China Pharmaceutical University/ Johnson and Johnson Innovation

Alternative Names: Nasal decongestants - China Pharmaceutical University, Johnson & Johnson Innovation; Pain therapeutics - China Pharmaceutical University, Johnson & Johnson Innovation

Latest Information Update: 04 Nov 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator China Pharmaceutical University; Johnson & Johnson Innovation
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Nasal congestion; Pain

Most Recent Events

  • 29 Oct 2014 Early research in Nasal congestion and Pain in China (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top